اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 20, Issue 4 (پائیز 1397) ::
Koomesh 1397, 20(4): 748-755 Back to browse issues page
Induction of apoptotic and anti-proliferative effects in REH cells upon neurokinin-1 receptor inhibition using Aprepitant
Elham Razani , A. va Safaroghli-Azar , Davood Bashash
Abstract:   (3775 Views)
Introduction: Following the first description of neurokinin-1 receptor (NK1R) network as a carcinogenic pathway, overwhelming numbers of studies have reported the inappropriate activity of this cascade in a wide assortment of human cancers. On the basis of the principal importance of NK1R in the pathogenesis of acute lymphoblastic leukemia (ALL), it was of great interest to dissect the effect of Aprepitant, a competing non-peptide NK1R antagonist, on REH Pre-B ALL cells. Materials and Methods: To evaluate the anti-leukemic effect of NK1R antagonist, REH cells were exposed to the increasing concentrations of Aprepitant and subsequent cell viability, growth kinetics, and metabolic activity were investigated. Moreover, to underscore whether Aprepitant-induced cytotoxic effect could be attributed to either induction of apoptosis or cell cycle arrest, Annexin-V/PI staining and DNA content analysis were performed. Finally, the transcriptional alterations of apoptosis-related target genes were studied using RQ-PCR. Results: Intrestingly, we found that abrogation of the NK1R signaling pathway exerts cytotoxic and anti-proliferative effects against REH cells, as evidenced by the increased externalization of phosphatidyl serine (PS), elevated G1 cell population, and decreased number of inhibitor-treated viable cells. In addition, our results also suggested that Aprepitant-induced apoptotic cell death in REH cells is mediated, at least partially, through shifting the ratio of death promoters to death repressors via alteration of Bax and Bcl2 expression. Conclusion: This study highlighted the potent efficacy of Aprepitant in Pre-B ALL cells and shed light on pro-apoptotic property of this inhibitor.  
Keywords: Acute Lymphoblastic Leukemia, Aprepitant, Apoptotic Cell Death, Neurokinin-1 Receptor, REH Cells
Full-Text [PDF 1981 kb]   (777 Downloads)    
Type of Study: Research | Subject: General
Received: 2017/11/8 | Accepted: 2018/04/30 | Published: 2018/09/23
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Razani E, Safaroghli-Azar A V, Bashash D. Induction of apoptotic and anti-proliferative effects in REH cells upon neurokinin-1 receptor inhibition using Aprepitant. Koomesh 1397; 20 (4) :748-755
URL: http://koomeshjournal.semums.ac.ir/article-1-4409-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 4 (پائیز 1397) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4645